Subscribe to RSS
Characteristics of Antibiotic-Resistant Bacteria in Libya Based on Different Source of Infections
In recent years and for decades, antimicrobial resistance (AMR) has expanded into a major clinical issue. Infections were no longer a life-threatening issue for clinicians after the discovery of antibiotics. The misuse or overuse of antibiotics, however, contributes to global AMR, and numerous mobile genetic elements and relevant resistant genes worsen the spread of resistance. As antibiotics lose their effectiveness, a growing number of infections such as pneumonia, tuberculosis, and gonorrhea are getting harder and sometimes impossible to treat. Infections that are resistant to antibiotics are correlated with antibiotic misuse. The majority of the antibiotic resistance in microbes is caused by improper use of antibiotics. Because there are a few antibiotics available to treat multidrug-resistant bacterial infections, there is a high rate of morbidity and mortality. Libya has a high burden of antibiotic resistance, and antimicrobial malpractice has frequently been reported. Providing information on the current state of antimicrobial resistance in Libya may assist the health authorities in addressing the problem more effectively in the future. Therefore, this review highlights the current situation of bacterial profile and their antimicrobial resistance in Libya based on the source of infection. Articles related to the topic were searched using databases and search engines such as PubMed, Google Scholar, and ResearchGate websites. These articles were selected if they were conducted in Libya and provided information on bacterial pathogens and AMR. Required data were extracted for the purpose of this review report, and then further verified for identifying the prevalence and number of susceptible and resistant pathogens in each source of infection.
The article has not been previously presented or published, and is not part of a thesis project.
Article published online:
19 December 2022
© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 1 Chiș AA, Rus LL, Morgovan C. et al. Microbial resistance to antibiotics and effective antibiotherapy. Biomedicines 2022; 10 (05) 1121 DOI: 10.3390/biomedicines10051121.
- 2 Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 2015; 109 (07) 309-318
- 3 Health Udo and H. Services. Antibiotic Resistance Threats in The United States, 2013, Centers for Disease Control and Prevention. Georgia, GA, USA: 2013
- 4 CDC report shows rise in resistant infections, deaths in first COVID-19 year. Accessed October 1, 2022, at: https://www.cidrap.umn.edu/news-perspective/2022/07/cdc-report-shows-rise-resistant-infections-deaths-first-covid-19-year
- 5 Schlander M, Hernandez-Villafuerte K, Cheng CY, Mestre-Ferrandiz J, Baumann M. How much does it cost to research and develop a new drug? A systematic review and assessment. PharmacoEconomics 2021; 39 (11) 1243-1269
- 6 World Health Organization. WHO publishes list of bacteria for which now antibiotics are urgently needed. Accessed October 1, 2022, at: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed
- 7 Breijyeh Z, Jubeh B, Karaman R. Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it. Molecules 2020; 25 (06) 1340 DOI: 10.3390/molecules25061340.
- 8 Gu J, Chen X, Yang Z, Bai Y, Zhang X. Gender differences in the microbial spectrum and antibiotic sensitivity of uropathogens isolated from patients with urinary stones. J Clin Lab Anal 2022; 36 (01) e24155 DOI: 10.1002/jcla.24155.
- 9 Ghenghesh K, Altomi A, Gashout S, Abouhagar B. High antimicrobial-resistance rates of Escherichia coli from urine specimens in Tripoli-Libya. Garyounis Med J 2003; 20: 89-93
- 10 Elsayah K, Atia A, Bkhait N. Antimicrobial resistance pattern of bacteria isolated from patients with urinary tract infection in Tripoli City, Libya. Asian J Pharm Health Sci 2017; 7 (04) 1751-1755
- 11 Ahmed M, Orwa J. Antimicrobial susceptibility of Escherichia coli urine isolates in South Libya. Sebha Med J. 2007; 6 (01) 46-50
- 12 Ghenghesh KS, Elkateb E, Berbash N. et al. Uropathogens from diabetic patients in Libya: virulence factors and phylogenetic groups of Escherichia coli isolates. J Med Microbiol 2009; 58 (Pt 8): 1006-1014 DOI: 10.1099/jmm.0.007146-0.
- 13 Wareg S, Foster H, Daw M. Antimicrobial susceptibility patterns of methicillin-resistant Staphylococcus aureus isolates collected from healthcare and community facilities in Libya show a high level of resistance to fusidic acid. J Infect Dis Ther 2014; 2: 189 DOI: 10.4172/2332-0877.1000189.
- 14 Ahmed MO, Alghazali MH, Abuzweda AR, Amri SG. Detection of inducible clindamycin resistance (MLSB(i)) among methicillin-resistant Staphylococcus aureus (MRSA) from Libya. Libyan J Med 2010; 5 (01) DOI: 10.3402/ljm.v5i0.4636.
- 15 Buzaid N, Elzouki AN, Taher I, Ghenghesh KS. Methicillin-resistant Staphylococcus aureus (MRSA) in a tertiary surgical and trauma hospital in Benghazi, Libya. J Infect Dev Ctries 2011; 5 (10) 723-726
- 16 Atia A, Abired A, Ammar A, Elyounsi N, Ashour A. Prevalence and types of bacterial infections of the upper respiratory tract at a tertiary care hospital in the City of Tripoli. Libyan Int Med Univ J 2018; 3: 54-58
- 17 Wang L, Qiao X, Ai L, Zhai J, Wang X. Isolation of antimicrobial resistant bacteria in upper respiratory tract infections of patients. 3 Biotech 2016; 6 (02) 166 DOI: 10.1007/s13205-016-0473-z.
- 18 Elkammoshi A, Ben Ashur A, El Magrahi H, Abdulatif A, Almarouq M. The role of bacterial colonization of ventilator circuit in development of ventilator associated pneumonia in ICU of Medical Center Hospital in Tripoli, Libya. Iberoam J Med 2021; 3 (02) 109-114
- 19 Atia A, Elyounsi N, Abired A, Wanis A, Ashour A. Antibiotic resistance pattern of bacteria isolated from patients with upper respiratory tract infections; a four year study in Tripoli city. Iberoam J Med. 2020; 2 (03) 155-160
- 20 Eldeeb A, Khashan E. Microbiological study on respiratory tract infections in Libya. Egypt J Hosp Med 2006; 24 (01) 442-459
- 21 Atia A, Ashour A, Shaban N, Omar F. Incidence of bacterial skin infections in Libya: a retrospective population-based study. Estudos Ibero-Americanos 2021; 3: 3-6 DOI: 10.5281/zenodo.4252549.
- 22 Abdalla A, Elzen A, Alshahed ASh. et al. Identification and determination of antibiotic resistance of pathogenic bacteria isolated from septic wounds. J Adv Lab Res Bio 2015; 6 (04) 97-101
- 23 Dau AA, Tloba S, Daw MA. Characterization of wound infections among patients injured during the 2011 Libyan conflict. East Mediterr Health J 2013; 19 (04) 356-361
- 24 Atia A. Prevalence of bacterial vaginosis and their antibiotic susceptibility among women attending different private clinics in Tripoli, Libya. Libyan J Med Sci 2021; 5: 79-82
- 25 Zorgani A, Elahmer O, Ziglam H, Ghenghesh K. In-vitro activity of tigecycline against methicillin-resistant Staphylococcus aureus isolated from wounds of burn patients in Tripoli-Libya. J Micr Infec Dise 2012; 2 (03) 109-112
- 26 Al-awkally N, Ali M, Al-awkally R, AL-awkally A, Ali F, Abouserwel A. Antibiotic susceptibility and resistant pattern of isolates of Pseudomonas aeruginosa recovered from infected swabs, abscess, burn, medical tips and blood from patients at 4 geographical locations in Libya (Al- Bayda, Shahat, Derna and Benghazi). Int J Curr Microbiol Appl Sci 2019; 8 (10) 143-149 DOI: 10.20546/ijcmas.2019.810.015.
- 27 Musa A, Nazeerullah R, Sarite S. Bacterial profile and antimicrobial susceptibility pattern of anterior blepharitis in Misurata region, Libya. Dent Med Res 2014; 2: 8-13
- 28 Elramalli A, Almshawt N, Ahmed MO. Current problematic and emergence of carbapenemase-producing bacteria: a brief report from a Libyan hospital. Pan Afr Med J 2017; 26: 180 DOI: 10.11604/pamj.2017.26.180.9637.